Browse by UCL Departments and Centres
Group by: Author | Type
Number of items: 191.
A
Abbosh, C;
Swanton, C;
(2021)
ctDNA: An emerging neoadjuvant biomarker in resectable solid tumors.
PLoS Medicine
, 18
(10)
, Article e1003771. 10.1371/journal.pmed.1003771.
|
Abbosh, Christopher;
(2021)
Cell-free DNA in early-stage non-small cell lung cancer.
Doctoral thesis (Ph.D), UCL (University College London).
|
Abdul-Jawad, S;
Baù, L;
Alaguthurai, T;
Del Molino Del Barrio, I;
Laing, AG;
Hayday, TS;
Monin, L;
... Irshad, S; + view all
(2021)
Acute immune signatures and their legacies in severe acute respiratory syndrome coronavirus-2 infected cancer patients.
Cancer Cell
10.1016/j.ccell.2021.01.001.
(In press).
|
Adams, RA;
Fisher, DJ;
Graham, J;
Seligmann, JF;
Seymour, M;
Kaplan, R;
Yates, E;
... FOCUS4 Trial Investigators; + view all
(2021)
Capecitabine Versus Active Monitoring in Stable or Responding Metastatic Colorectal Cancer After 16 Weeks of First-Line Therapy: Results of the Randomized FOCUS4-N Trial.
Journal of clinical oncology: official journal of the American Society of Clinical Oncology
10.1200/JCO.21.01436.
(In press).
|
Ahmed, Mahbubl;
Collins, Shane;
Bacon, Andrew;
Franks, Joanna;
Lobo, Cheryl;
Paley, Lizz;
Strauss, Sandra;
(2021)
08. Incidence and outcome of breast sarcomas in NHS England (2013-2018): An analysis from Public Health England (PHE) National Cancer Registration and Analysis Service (NCRAS).
European Journal of Surgical Oncology
, 47
(5)
e288-e288.
10.1016/j.ejso.2021.03.204.
|
Akay, M;
Funingana, I-G;
Patel, G;
Mustapha, R;
Gjafa, E;
Ng, T;
Ng, K;
(2021)
An In-Depth Review of Niraparib in Ovarian Cancer: Mechanism of Action, Clinical Efficacy and Future Directions.
Oncology and Therapy
10.1007/s40487-021-00167-z.
(In press).
|
Ali, A;
Hoyle, AP;
Parker, CC;
Brawley, CD;
Cook, A;
Amos, C;
Calvert, J;
... STAMPEDE investigators; + view all
(2021)
Bone metastatic burden as a predictor of survival benefit from prostate radiotherapy in newly-diagnosed metastatic prostate cancer.
JAMA oncology
, 7
(4)
pp. 555-563.
10.1001/jamaoncol.2020.7857.
|
Alliouachene, S;
Kieswich, JE;
Bilanges, B;
McCafferty, K;
Thiemermann, C;
Vanhaesebroeck, B;
Yaqoob, MM;
(2021)
Uninephrectomy and class II PI3K-C2β inactivation synergistically protect against obesity, insulin resistance and liver steatosis in mice.
American Journal of Transplantation
10.1111/ajt.16470.
(In press).
|
Anquetil, T;
Solinhac, R;
Jaffre, A;
Chicanne, G;
Viaud, J;
Darcourt, J;
Orset, C;
... Gratacap, M-P; + view all
(2021)
PI3KC2β inactivation stabilizes VE-cadherin junctions and preserves vascular integrity.
EMBO Reports
, 22
(6)
, Article e51299. 10.15252/embr.202051299.
|
Arshad, R;
Tabish, TA;
Kiani, MH;
Ibrahim, IM;
Shahnaz, G;
Rahdar, A;
Kang, M;
(2021)
A Hyaluronic Acid Functionalized Self-Nano-Emulsifying Drug Delivery System (SNEDDS) for Enhancement in Ciprofloxacin Targeted Delivery against Intracellular Infection.
Nanomaterials
, 11
(5)
, Article 1086. 10.3390/nano11051086.
|
Attard, G;
Brown, LC;
Clarke, NW;
Parmar, MKB;
James, ND;
(2021)
Should Patients with High-risk Localised or Locally Advanced Prostate Cancer Receive Abiraterone Acetate in Addition to Androgen Deprivation Therapy? Update on a Planned Analysis of the STAMPEDE Trial.
European Urology
, 80
(4)
pp. 522-523.
10.1016/j.eururo.2021.06.023.
|
Attard, G;
Murphy, L;
Clarke, NW;
Cross, W;
Jones, RJ;
Parker, CC;
Gillessen, S;
... Systemic Therapy in Advancing or Metastatic Prostate cancer: Eva; + view all
(2021)
Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol.
The Lancet
10.1016/S0140-6736(21)02437-5.
(In press).
|
Au, L;
Hatipoglu, E;
Robert de Massy, M;
Litchfield, K;
Beattie, G;
Rowan, A;
Schnidrig, D;
... TRACERx Renal Consortium; + view all
(2021)
Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma.
Cancer Cell
, 39
pp. 1497-1518.
10.1016/j.ccell.2021.10.001.
|
Au, L;
Fendler, A;
Shepherd, STC;
Rzeniewicz, K;
Cerrone, M;
Byrne, F;
Carlyle, E;
... Turajlic, S; + view all
(2021)
Cytokine release syndrome in a patient with colorectal cancer after vaccination with BNT162b2.
Nature Medicine
10.1038/s41591-021-01387-6.
|
B
Bailey, C;
Black, JRM;
Reading, JL;
Litchfield, K;
Turajlic, S;
McGranahan, N;
Jamal-Hanjani, M;
(2021)
Tracking Cancer Evolution through the Disease Course.
Cancer Discovery
, 11
(4)
pp. 916-932.
10.1158/2159-8290.CD-20-1559.
|
Balestrini, S;
Koepp, MJ;
Gandhi, S;
Rickman, HM;
Yen Shin, G;
Houlihan, CF;
Anders-Cannon, J;
... Sisodiya, SM; + view all
(2021)
Clinical outcomes of COVID-19 in long-term care facilities for people with epilepsy.
Epilepsy & Behavior
, 115
, Article 107602. 10.1016/j.yebeh.2020.107602.
|
Banfill, K;
Croxford, W;
Fornacon-Wood, I;
Wicks, K;
Ahmad, S;
Britten, A;
Carson, C;
... Faivre-Finn, C; + view all
(2021)
Changes in the Management of Patients having Radical Radiotherapy for Lung Cancer during the First Wave of the COVID-19 Pandemic in the UK.
Clinical Oncology
10.1016/j.clon.2021.10.009.
(In press).
|
Bartlett, JMS;
Bayani, J;
Kornaga, E;
Xu, K;
Pond, GR;
Piper, T;
Mallon, E;
... Rea, D; + view all
(2021)
Comparative survival analysis of multiparametric tests-when molecular tests disagree-A TEAM Pathology study.
NPJ Breast Cancer
, 7
(1)
, Article 90. 10.1038/s41523-021-00297-7.
|
Bentham, R;
Litchfield, K;
Watkins, TBK;
Lim, EL;
Rosenthal, R;
Martinez-Ruiz, C;
Hiley, CT;
... McGranahan, N; + view all
(2021)
Using DNA sequencing data to quantify T cell fraction and therapy response.
Nature
, 597
pp. 555-560.
10.1038/s41586-021-03894-5.
|
Bertaglia, V;
Reale, ML;
Bironzo, P;
Palesandro, E;
Mariniello, A;
Leone, G;
Tabbò, F;
... Novello, S; + view all
(2021)
Italian survey on the clinical management of non-small cell lung cancer patients during the COVID-19 pandemic: A lesson for the second wave.
Critical Reviews in Oncology/Hematology
, 157
, Article 103189. 10.1016/j.critrevonc.2020.103189.
|
Best, J;
Starkey, T;
Chaterjee, A;
Fackrell, D;
Pettit, L;
Srihari, N;
Tween, H;
... Lee, LYW; + view all
(2021)
Coronavirus Disease 2019: the Pivotal Role of UK Clinical Oncology and the UK Coronavirus Cancer Monitoring Project.
Clinical Oncology
, 33
(1)
e50-e53.
10.1016/j.clon.2020.05.021.
|
Black, JRM;
McGranahan, N;
(2021)
Genetic and non-genetic clonal diversity in cancer evolution.
Nature Reviews Cancer
, 21
(6)
pp. 379-392.
10.1038/s41568-021-00336-2.
|
Bofinger, R;
Weitsman, G;
Evans, R;
Glaser, M;
Sander, K;
Allan, H;
Hochhauser, D;
... Tabor, AB; + view all
(2021)
Drug delivery, biodistribution and anti-EGFR activity: theragnostic nanoparticles for simultaneous in vivo delivery of tyrosine kinase inhibitors and kinase activity biosensors.
Nanoscale
10.1039/d1nr02770k.
(In press).
|
Booth, S;
Curley, HM;
Varnai, C;
Arnold, R;
Lee, LYW;
Campton, NA;
Cook, G;
... Palles, C; + view all
(2021)
Key findings from the UKCCMP cohort of 877 patients with haematological malignancy and COVID-19: disease control as an important factor relative to recent chemotherapy or anti-CD20 therapy.
British Journal of Haematology
10.1111/bjh.17937.
(In press).
|
Bortolomeazzi, M;
Keddar, MR;
Montorsi, L;
Acha-Sagredo, A;
Benedetti, L;
Temelkovski, D;
Choi, S;
... Ciccarelli, FD; + view all
(2021)
Immunogenomics of Colorectal Cancer Response to Checkpoint Blockade: Analysis of the KEYNOTE 177 Trial and Validation Cohorts.
Gastroenterology
10.1053/j.gastro.2021.06.064.
(In press).
|
Brooks, LJ;
Clements, MP;
Burden, JJ;
Kocher, D;
Richards, L;
Devesa, SC;
Zakka, L;
... Parrinello, S; + view all
(2021)
The white matter is a pro-differentiative niche for glioblastoma.
Nature Communications
, 12
, Article 2184. 10.1038/s41467-021-22225-w.
|
Buck, M;
Poirier, E;
Cardoso, A;
Frederico, B;
Canton, J;
Barrell, S;
Beale, R;
... The Crick COVID-19 Consortium; + view all
(2021)
SARS-CoV-2 detection by a clinical diagnostic RT-LAMP assay [version 1; peer review: 1 approved with reservations].
Wellcome Open Research
, 6
(9)
10.12688/wellcomeopenres.16517.1.
|
Buck, MD;
Poirier, EZ;
Cardoso, A;
Frederico, B;
Canton, J;
Barrell, S;
Beale, R;
... Crick COVID-19 Consortium; + view all
(2021)
SARS-CoV-2 detection by a clinical diagnostic RT-LAMP assay.
Wellcome Open Research
, 6
, Article 9. 10.12688/wellcomeopenres.16517.2.
|
Busacca, S;
Zhang, Q;
Sharkey, A;
Dawson, AG;
Moore, DA;
Waller, DA;
Nakas, A;
... Fennell, DA; + view all
(2021)
Transcriptional perturbation of protein arginine methyltransferase-5 exhibits MTAP-selective oncosuppression.
Scientific Reports
, 11
(1)
, Article 7434. 10.1038/s41598-021-86834-7.
|
Byers, LA;
Navarro, A;
Schaefer, E;
Johnson, M;
Özgüroğlu, M;
Han, J-Y;
Bondarenko, I;
... Forster, M; + view all
(2021)
A Phase II Trial of Prexasertib (LY2606368) in Patients With Extensive-Stage Small-Cell Lung Cancer.
Clinical Lung Cancer
, 22
(6)
pp. 531-540.
10.1016/j.cllc.2021.04.005.
|
C
Cabrera, R;
Singal, AG;
Colombo, M;
Kelley, RK;
Lee, H;
Mospan, AR;
Meyer, T;
... Di Bisceglie, AM; + view all
(2021)
A Real-World Observational Cohort of Patients with Hepatocellular Carcinoma: Design and Rationale for TARGET-HCC.
Hepatology Communications
, 5
(3)
pp. 538-547.
10.1002/hep4.1652.
|
Cai, H;
Chew, SK;
Li, C;
Tsai, MK;
Andrejka, L;
Murray, CW;
Hughes, NW;
... Winslow, MM; + view all
(2021)
A Functional Taxonomy of Tumor Suppression in Oncogenic KRAS-Driven Lung Cancer.
Cancer Discovery
, 11
(7)
pp. 1754-1773.
10.1158/2159-8290.CD-20-1325.
|
Carter, TJ;
Agliardi, G;
Lin, F-Y;
Ellis, M;
Jones, C;
Robson, M;
Richard-Londt, A;
... Chester, K; + view all
(2021)
Potential of Magnetic Hyperthermia to Stimulate Localized Immune Activation.
Small
, Article e2005241. 10.1002/smll.202005241.
(In press).
|
Chambers, P;
Wei, L;
Forster, MD;
Kipps, E;
Wong, ICK;
Jani, Y;
(2021)
Evidence to guide the optimal timing for pre-chemotherapy blood tests for early breast, colorectal cancer and diffuse large B-cell lymphoma.
Cancer Medicine
10.1002/cam4.4316.
(In press).
|
Chen, M;
Chen, R;
Jin, Y;
Li, J;
Hu, X;
Zhang, J;
Fujimoto, J;
... Zhang, J; + view all
(2021)
Cold and heterogeneous T cell repertoire is associated with copy number aberrations and loss of immune genes in small-cell lung cancer.
Nature Communications
, 12
, Article 6655. 10.1038/s41467-021-26821-8.
|
Chen, X;
Zhabyeyev, P;
Azad, AK;
Vanhaesebroeck, B;
Grueter, CE;
Murray, AG;
Kassiri, Z;
(2021)
Pharmacological and cell-specific genetic PI3Kα inhibition worsens cardiac remodeling after myocardial infarction.
Journal of Molecular and Cellular Cardiology
, 157
pp. 17-30.
10.1016/j.yjmcc.2021.04.004.
|
Chen, S-H;
Miles, K;
Taylor, SA;
Ganeshan, B;
Rodriquez, M;
Fraioli, F;
Wan, S;
... Groves, A; + view all
(2021)
FDG-PET/CT in colorectal cancer: potential for vascular-metabolic imaging to provide markers of prognosis.
European Journal of Nuclear Medicine and Molecular Imaging
10.1007/s00259-021-05318-y.
(In press).
|
Childs, A;
Zakeri, N;
Ma, YT;
O’Rourke, J;
Ross, P;
Hashem, E;
Hubner, RA;
... Meyer, T; + view all
(2021)
Biopsy for advanced hepatocellular carcinoma: results of a multicentre UK audit.
British Journal of Cancer
10.1038/s41416-021-01535-2.
(In press).
|
Childs, A;
Steele, CD;
Vesely, C;
Rizzo, FMM;
Ensell, L;
Lowe, H;
Dhami, P;
... Meyer, T; + view all
(2021)
Whole genome sequencing of single circulating tumor cells from neuroendocrine neoplasms.
Endocrine-Related Cancer
10.1530/ERC-21-0179.
(In press).
|
Chung, C-Y;
Singh, K;
Kotiadis, VN;
Valdebenito, GE;
Ahn, JH;
Topley, E;
Tan, J;
... Duchen, MR; + view all
(2021)
Constitutive activation of the PI3K-Akt-mTORC1 pathway sustains the m.3243 A > G mtDNA mutation.
Nature Communications
, 12
(1)
, Article 6409. 10.1038/s41467-021-26746-2.
|
Collier, DA;
De Marco, A;
Ferreira, IATM;
Meng, B;
Datir, RP;
Walls, AC;
Kemp, SA;
... Gupta, RK; + view all
(2021)
Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies.
Nature
, 593
pp. 136-141.
10.1038/s41586-021-03412-7.
|
Conforti, F;
Pala, L;
Pagan, E;
Bagnardi, V;
De Pas, T;
Queirolo, P;
Pennacchioli, E;
... Giaccone, G; + view all
(2021)
Sex-Based Dimorphism of Anticancer Immune Response and Molecular Mechanisms of Immune Evasion.
Clinical Cancer Research
, 27
(15)
pp. 4311-4324.
10.1158/1078-0432.CCR-21-0136.
|
Cortellini, A;
De Giglio, A;
Cannita, K;
Cortinovis, DL;
Cornelissen, R;
Baldessari, C;
Giusti, R;
... Porzio, G; + view all
(2021)
Smoking status during first-line immunotherapy and chemotherapy in NSCLC patients: A case–control matched analysis from a large multicenter study.
Thoracic Cancer
, 12
(6)
pp. 880-889.
10.1111/1759-7714.13852.
|
D
de Silva, TI;
Liu, G;
Lindsey, BB;
Dong, D;
Moore, SC;
Hsu, NS;
Shah, D;
... Dong, T; + view all
(2021)
The impact of viral mutations on recognition by SARS-CoV-2 specific T cells.
iScience
, 24
(11)
, Article 103353. 10.1016/j.isci.2021.103353.
|
Dejima, Hitoshi;
Hu, Xin;
Chen, Runzhe;
Zhang, Jiexin;
Fujimoto, Junya;
Parra, Edwin R;
Haymaker, Cara;
... Zhang, Jianjun; + view all
(2021)
Immune evolution from preneoplasia to invasive lung adenocarcinomas and underlying molecular features.
Nature Communications
, 12
(1)
, Article 2722. 10.1038/s41467-021-22890-x.
|
Dentro, SC;
Leshchiner, I;
Haase, K;
Tarabichi, M;
Wintersinger, J;
Deshwar, AG;
Yu, K;
... PCAWG Evolution and Heterogeneity Working Group and the PCAWG Co, .; + view all
(2021)
Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes.
Cell
, 184
(8)
pp. 2239-2254.
10.1016/j.cell.2021.03.009.
|
Dettorre, GM;
Dolly, S;
Loizidou, A;
Chester, J;
Jackson, A;
Mukherjee, U;
Zambelli, A;
... OnCovid study group; + view all
(2021)
Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score.
Journal for ImmunoTherapy of Cancer
, 9
(3)
, Article e002277. 10.1136/jitc-2020-002277.
|
Ding, H;
Velasco, C;
Ye, H;
Lindner, T;
Grech-Sollars, M;
O'Callaghan, J;
Hiley, C;
... Adeleke, S; + view all
(2021)
Current Applications and Future Development of Magnetic Resonance Fingerprinting in Diagnosis, Characterization, and Response Monitoring in Cancer.
Cancers
, 13
(19)
, Article 4742. 10.3390/cancers13194742.
|
Dujon, Antoine M;
Aktipis, Athena;
Alix-Panabieres, Catherine;
Amend, Sarah R;
Boddy, Amy M;
Brown, Joel S;
Capp, Jean-Pascal;
... Ujvari, Beata; + view all
(2021)
Identifying key questions in the ecology and evolution of cancer.
Evolutionary Applications
, 14
(4)
pp. 877-892.
10.1111/eva.13190.
|
E
El Bairi, K;
Haynes, HR;
Blackley, E;
Fineberg, S;
Shear, J;
Turner, S;
de Freitas, JR;
... Bautista, V; + view all
(2021)
The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group.
npj Breast Cancer
, 7
, Article 150. 10.1038/s41523-021-00346-1.
|
Emanuel, O;
Liu, J;
Schartinger, VH;
Nei, WL;
Chan, YY;
Tsang, CM;
Riechelmann, H;
... Lechner, M; + view all
(2021)
SSTR2 in Nasopharyngeal Carcinoma: Relationship with Latent EBV Infection and Potential as a Therapeutic Target.
Cancers
, 13
(19)
, Article 4944. 10.3390/cancers13194944.
|
Evison, M;
Barrett, E;
Cheng, A;
Mulla, A;
Walls, G;
Johnston, D;
McAleese, J;
... Faivre-Finn, C; + view all
(2021)
Predicting the Risk of Disease Recurrence and Death Following Curative-intent Radiotherapy for Non-small Cell Lung Cancer: The Development and Validation of Two Scoring Systems From a Large Multicentre UK Cohort.
Clinical Oncology
, 33
(3)
pp. 145-154.
10.1016/j.clon.2020.09.001.
|
F
Fendler, A;
Au, L;
Shepherd, STC;
Byrne, F;
Cerrone, M;
Boos, LA;
Rzeniewicz, K;
... Wilkinson, RJ; + view all
(2021)
Functional antibody and T cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study.
Nature Cancer
10.1038/s43018-021-00275-9.
(In press).
|
Fendler, A;
Shepherd, STC;
Au, L;
Wilkinson, KA;
Wu, M;
Byrne, F;
Cerrone, M;
... Turajlic, S; + view all
(2021)
Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study.
Nature Cancer
10.1038/s43018-021-00274-w.
(In press).
|
Fendler, Annika;
Au, Lewis;
Shepherd, Scott TC;
Byrne, Fiona;
Cerrone, Maddalena;
Boos, Laura Amanda;
Rzeniewicz, Karolina;
... Turajlic, Samra; + view all
(2021)
Functional antibody and T-cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study.
Research Square: Durham, NC, USA.
|
Feng, FY;
Huang, H-C;
Spratt, DE;
Zhao, SG;
Sandler, HM;
Simko, JP;
Davicioni, E;
... Tran, PT; + view all
(2021)
Validation of a 22-Gene Genomic Classifier in Patients With Recurrent Prostate Cancer An Ancillary Study of the NRG/RTOG 9601 Randomized Clinical Trial.
JAMA Oncology
, 7
(4)
pp. 544-552.
10.1001/jamaoncol.2020.7671.
|
Fu, X;
Zhao, Y;
Lopez, JI;
Rowan, A;
Au, L;
Fendler, A;
Hazell, S;
... Bates, PA; + view all
(2021)
Spatial patterns of tumour growth impact clonal diversification in a computational model and the TRACERx Renal study.
Nature Ecology & Evolution
10.1038/s41559-021-01586-x.
|
G
Ganeshan, B;
Miles, K;
Afaq, A;
Punwani, S;
Rodriguez, M;
Wan, S;
Walls, D;
... Groves, A; + view all
(2021)
Texture Analysis of Fractional Water Content Images Acquired during PET/MRI: Initial Evidence for an Association with Total Lesion Glycolysis, Survival and Gene Mutation Profile in Primary Colorectal Cancer.
Cancers
, 13
(11)
, Article 2715. 10.3390/cancers13112715.
|
Garrigós, L;
Saura, C;
Martinez-Vila, C;
Zambelli, A;
Bower, M;
Pistilli, B;
Lambertini, M;
... Gennari, A; + view all
(2021)
COVID-19 in breast cancer patients: a subanalysis of the OnCovid registry.
Therapeutic Advances in Medical Oncology
, 13
pp. 1-11.
10.1177/17588359211053416.
|
Gaspar, N;
Campbell-Hewson, Q;
Gallego Melcon, S;
Locatelli, F;
Venkatramani, R;
Hecker-Nolting, S;
Gambart, M;
... Casanova, M; + view all
(2021)
Phase I/II study of single-agent lenvatinib in children and adolescents with refractory or relapsed solid malignancies and young adults with osteosarcoma (ITCC-050).
ESMO Open
, 6
(5)
, Article 100250. 10.1016/j.esmoop.2021.100250.
|
Gaspar, N;
Venkatramani, R;
Hecker-Nolting, S;
Melcon, SG;
Locatelli, F;
Bautista, F;
Longhi, A;
... Campbell-Hewson, Q; + view all
(2021)
Lenvatinib with etoposide plus ifosfamide in patients with refractory or relapsed osteosarcoma (ITCC-050): a multicentre, open-label, multicohort, phase 1/2 study.
Lancet Oncology
, 22
(9)
pp. 1312-1321.
10.1016/S1470-2045(21)00387-9.
|
Glosli, H;
Bisogno, G;
Kelsey, A;
Chisholm, JC;
Gaze, M;
Kolb, F;
McHugh, K;
... Orbach, D; + view all
(2021)
Non-parameningeal head and neck rhabdomyosarcoma in children, adolescents, and young adults: Experience of the European paediatric Soft tissue sarcoma Study Group (EpSSG) – RMS2005 study.
European Journal of Cancer
, 151
pp. 84-93.
10.1016/j.ejca.2021.04.007.
|
Goyal, L;
Kongpetch, S;
Crolley, VE;
Bridgewater, J;
(2021)
Targeting FGFR inhibition in cholangiocarcinoma.
Cancer Treatment Reviews
, 95
, Article 102170. 10.1016/j.ctrv.2021.102170.
|
Graham, MS;
Sudre, CH;
May, A;
Antonelli, M;
Murray, B;
Varsaysky, T;
Klaser, K;
... Ourselin, S; + view all
(2021)
Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study.
Lancet Public Health
, 6
(5)
E335-E345.
10.1016/S2468-2667(21)00055-4.
|
Green, S;
Tuck, S;
Long, J;
Green, T;
Green, A;
Ellis, P;
Haire, A;
... Van Hemelrijck, M; + view all
(2021)
ReIMAGINE: a prostate cancer research consortium with added value through its patient and public involvement and engagement.
Research Involvement and Engagement
, 7
(1)
, Article 81. 10.1186/s40900-021-00322-w.
|
Gronchi, A;
Miah, AB;
DeiTos, AP;
Abecassis, N;
Bajpai, J;
Bauer, S;
Biagini, R;
... Stacchiotti, S; + view all
(2021)
Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Annals of Oncology
, 32
(11)
pp. 1348-1365.
10.1016/j.annonc.2021.07.006.
|
Gundogdu, R;
Erdogan, MK;
Ditsiou, A;
Spanswick, V;
Garcia-Gomez, JJ;
Hartley, JA;
Esashi, F;
... Gomez, V; + view all
(2021)
hMOB2 deficiency impairs homologous recombination-mediated DNA repair and sensitises cancer cells to PARP inhibitors.
Cellular Signalling
, 87
, Article 110106. 10.1016/j.cellsig.2021.110106.
|
Guo, C;
Crespo, M;
Gurel, B;
Dolling, D;
Rekowski, J;
Sharp, A;
Petremolo, A;
... International SU2C PCF Prostate Cancer Dream Team, .; + view all
(2021)
CD38 in Advanced Prostate Cancers.
European Urology
, 79
(6)
pp. 736-746.
10.1016/j.eururo.2021.01.017.
|
H
Hamid, AA;
Huang, H-C;
Wang, V;
Chen, Y-H;
Feng, F;
Den, R;
Attard, G;
... Sweeney, CJ; + view all
(2021)
Transcriptional profiling of primary prostate tumor in metastatic hormone-sensitive prostate cancer and association with clinical outcomes: correlative analysis of the E3805 CHAARTED trial.
Annals of Oncology
, 32
(9)
pp. 1157-1166.
10.1016/j.annonc.2021.06.003.
|
Han, G;
Yang, G;
Hao, D;
Lu, Y;
Thein, K;
Simpson, BS;
Chen, J;
... Wang, L; + view all
(2021)
9p21 loss confers a cold tumor immune microenvironment and primary resistance to immune checkpoint therapy.
Nature Communications
, 12
, Article 5606. 10.1038/s41467-021-25894-9.
|
Hartley, JA;
(2021)
Antibody-drug conjugates (ADCs) delivering pyrrolobenzodiazepine (PBD) dimers for cancer therapy.
Expert Opinion on Biological Therapy
, 21
(7)
pp. 931-943.
10.1080/14712598.2020.1776255.
|
Hayes, AR;
Mak, IYF;
Evans, N;
Naik, R;
Crawford, A;
Khoo, B;
Grossman, AB;
... Meyer, T; + view all
(2021)
Understanding the Treatment Algorithm of Patients with Metastatic Pancreatic Neuroendocrine Neoplasms: A Single-Institution Retrospective Analysis Comparing Outcomes of Chemotherapy, Molecular Targeted Therapy, and Peptide Receptor Radionuclide Therapy in 255 Patients.
Neuroendocrinology
, 111
(9)
pp. 863-875.
10.1159/000511662.
|
Hellewell, J;
Russell, TW;
SAFER Investigators and Field Study Team, ,;
Crick COVID-19 Consortium, ,;
CMMID COVID-19 working group, ,;
Beale, R;
Kelly, G;
... Kucharski, AJ; + view all
(2021)
Estimating the effectiveness of routine asymptomatic PCR testing at different frequencies for the detection of SARS-CoV-2 infections.
BMC Medicine
, 19
(1)
, Article 106. 10.1186/s12916-021-01982-x.
|
Hernando, B;
Dietzen, M;
Parra, G;
Gil-Barrachina, M;
Pitarch, G;
Mahiques, L;
Valcuende-Cavero, F;
... Martinez-Cadenas, C; + view all
(2021)
The effect of age on the acquisition and selection of cancer driver mutations in sun-exposed normal skin.
Annals of Oncology
, 32
(3)
pp. 412-421.
10.1016/j.annonc.2020.11.023.
|
Hofmann, MR;
Hussain, M;
Dehm, SM;
Beltran, H;
Wyatt, AW;
Halabi, S;
Sweeney, C;
... Sharifi, N; + view all
(2021)
Prostate Cancer Foundation Hormone-Sensitive Prostate Cancer Biomarker Working Group Meeting Summary.
Urology
, 155
pp. 165-171.
10.1016/j.urology.2020.12.021.
|
Hu, Xin;
Estecio, Marcos R;
Chen, Runzhe;
Reuben, Alexandre;
Wang, Linghua;
Fujimoto, Junya;
Carrot-Zhang, Jian;
... Zhang, Jianjun; + view all
(2021)
Evolution of DNA methylome from precancerous lesions to invasive lung adenocarcinomas.
Nature Communications
, 12
, Article 687. 10.1038/s41467-021-20907-z.
|
Huebner, A;
Dietzen, M;
McGranahan, N;
(2021)
SnapShot: Tumor evolution.
Cell
, 184
(6)
1650-1650.e1.
10.1016/j.cell.2021.02.024.
|
Huijskens, SC;
Kroon, PS;
Gaze, MN;
Gandola, L;
Bolle, S;
Supiot, S;
Abakay, CD;
... Janssens, GO; + view all
(2021)
Radical radiotherapy for paediatric solid tumour metastases: An overview of current European protocols and outcomes of a SIOPE multicenter survey.
European Journal of Cancer
, 145
pp. 121-131.
10.1016/j.ejca.2020.12.004.
|
Hynds, RE;
Frese, KK;
Pearce, DR;
Grönroos, E;
Dive, C;
Swanton, C;
(2021)
Progress towards non-small-cell lung cancer models that represent clinical evolutionary trajectories.
Open Biology
, 11
(1)
, Article 200247. 10.1098/rsob.200247.
|
Hynds, RE;
Zacharias, WJ;
Nikolić, MZ;
Königshoff, M;
Eickelberg, O;
Gosens, R;
de Coppi, P;
... Lin, QS; + view all
(2021)
National Heart, Lung and Blood Institute and Building Respiratory Epithelium and Tissue for Health (BREATH) Consortium Workshop Report: Moving Forward in Lung Regeneration.
American Journal of Respiratory Cell and Molecular Biology
10.1165/rcmb.2020-0397WS.
(In press).
|
I
Ingley, KM;
Hughes, D;
Hubank, M;
Lindsay, D;
Plumb, A;
Cox, R;
Chesler, L;
(2021)
Durable response to serial tyrosine kinase inhibitors (TKIs) in an adolescent with metastatic TFG-ROS1 fusion positive Inflammatory Myofibroblastic Tumor (IMT).
Lung Cancer
, 158
pp. 151-155.
10.1016/j.lungcan.2021.05.024.
|
Ingley, KM;
Wan, S;
Vöö, S;
Windsor, R;
Michelagnoli, M;
Saifuddin, A;
Strauss, SJ;
(2021)
Is It Time to Call Time on Bone Marrow Biopsy for Staging Ewing Sarcoma (ES)?
Cancers
, 13
(13)
, Article 3261. 10.3390/cancers13133261.
|
J
Jayaram, A;
Wingate, A;
Wetterskog, D;
Wheeler, G;
Sternberg, CN;
Jones, R;
Berruti, A;
... Attard, G; + view all
(2021)
Plasma tumor gene conversions after one cycle abiraterone acetate for metastatic castration-resistant prostate cancer: a biomarker analysis of a multi-center international trial.
Annals of Oncology
, 32
(6)
pp. 726-735.
10.1016/j.annonc.2021.03.196.
|
Jayaram, Anuradha Krishna;
(2021)
Leveraging circulating tumour DNA to dissect the evolutionary genomic dynamics of drug resistance in prostate cancer.
Doctoral thesis (Ph.D), UCL (University College London).
|
K
Kapriniotis, K;
Bania, A;
Lampridis, S;
Geropoulos, G;
Mitsos, S;
Monk, F;
Moore, DA;
(2021)
Metastatic mandibular ameloblastoma of the lung ten years after primary resection: A rare case report.
Monaldi Archives for Chest Disease
, 91
(2)
, Article 1643. 10.4081/monaldi.2021.1643.
|
Keane, Lily;
Antignano, Ignazio;
Riechers, Sean-Patrick;
Zollinger, Raphael;
Dumas, Anaelle A;
Offermann, Nina;
Bernis, Maria E;
... Capasso, Melania; + view all
(2021)
mTOR-dependent translation amplifies microglia priming in aging mice.
Journal of Clinical Investigation
, 131
(1)
, Article e132727. 10.1172/JCI132727.
|
Kelley, RK;
Miksad, R;
Cicin, I;
Chen, Y;
Klümpen, H-J;
Kim, S;
Lin, Z-Z;
... Abou-Alfa, GK; + view all
(2021)
Efficacy and safety of cabozantinib for patients with advanced hepatocellular carcinoma based on albumin-bilirubin grade.
British Journal of Cancer
10.1038/s41416-021-01532-5.
(In press).
|
Kemp, SA;
Collier, DA;
Datir, RP;
Ferreira, IATM;
Gayed, S;
Jahun, A;
Hosmillo, M;
... Gupta, RK; + view all
(2021)
SARS-CoV-2 evolution during treatment of chronic infection.
Nature
, 592
pp. 277-282.
10.1038/s41586-021-03291-y.
|
Khalil, AME;
Memon, FA;
Tabish, TA;
Fenton, B;
Salmon, D;
Zhang, S;
Butler, D;
(2021)
Performance Evaluation of Porous Graphene as Filter Media for the Removal of Pharmaceutical/Emerging Contaminants from Water and Wastewater.
Nanomaterials
, 11
(1)
, Article 79. 10.3390/nano11010079.
|
Kim, YJ;
Sheu, KM;
Tsoi, J;
Abril-Rodriguez, G;
Medina, E;
Grasso, CS;
Torrejon, DY;
... Ribas, A; + view all
(2021)
Melanoma dedifferentiation induced by IFN-γ epigenetic remodeling in response to anti–PD-1 therapy.
The Journal of Clinical Investigation
, 131
(12)
, Article e145859. 10.1172/JCI145859.
|
Klein, EA;
Richards, D;
Cohn, A;
Tummala, M;
Lapham, R;
Cosgrove, D;
Chung, G;
... Liu, MC; + view all
(2021)
Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set.
Annals of Oncology
10.1016/j.annonc.2021.05.806.
(In press).
|
Kristeleit, R;
Moreno, V;
Boni, V;
Guerra, EM;
Kahatt, C;
Romero, I;
Calvo, E;
... Forster, M; + view all
(2021)
Doxorubicin plus lurbinectedin in patients with advanced endometrial cancer: Results from an expanded phase i study.
International Journal of Gynecological Cancer
, 31
(11)
pp. 1428-1436.
10.1136/ijgc-2021-002881.
|
Kristensen, NP;
Heeke, C;
Tvingsholm, SA;
Borch, A;
Draghi, A;
Crowther, MD;
Carri, I;
... Hadrup, SR; + view all
(2021)
Neoantigen-reactive CD8+ T cells affect clinical outcome of adoptive transfer with tumor-infiltrating lymphocytes in melanoma.
Journal of Clinical Investigation
10.1172/JCI150535.
(In press).
|
L
Lau, Evelyn Keet Wai;
(2021)
Genomic and epigenomic impact of oncogenic mutation in the PIK3CA gene.
Doctoral thesis (Ph.D), UCL (University College London).
|
Lauder, SN;
Vanhaesebroeck, B;
Gallimore, A;
(2021)
Sequential targeting of PI3Kδ and LAG3 as an effective anti-cancer approach.
British Journal of Cancer
10.1038/s41416-021-01285-1.
(In press).
|
Lecat, Catherine SY;
Rodriguez-Justo, Manuel;
Patel, Dominic;
Yong, Kwee;
Papanikolaou, Xenofon;
(2021)
A rare case of relapsed multiple myeloma with aberrant T-cell antigen expression and skin plasmacytomas.
eJHaem
, 2
(2)
pp. 301-302.
10.1002/jha2.172.
|
Lechner, M;
Schartinger, VH;
Steele, CD;
Nei, WL;
Ooft, ML;
Schreiber, L-M;
Pipinikas, CP;
... Lund, VJ; + view all
(2021)
Somatostatin receptor 2 expression in nasopharyngeal cancer is induced by Epstein Barr virus infection: impact on prognosis, imaging and therapy.
Nature Communications
, 12
(1)
, Article 117. 10.1038/s41467-020-20308-8.
|
Lee, AJX;
Purshouse, K;
(2021)
COVID-19 and cancer registries: learning from the first peak of the SARS-CoV-2 pandemic.
British Journal of Cancer
10.1038/s41416-021-01324-x.
(In press).
|
Lee, DDH;
Cardinale, D;
Nigro, E;
Butler, CR;
Rutman, A;
Fassad, MR;
Hirst, RA;
... O'Callaghan, C; + view all
(2021)
Higher throughput drug screening for rare respiratory diseases: Readthrough therapy in primary ciliary dyskinesia.
European Respiratory Journal
10.1183/13993003.00455-2020.
(In press).
|
Li, J;
Duran, MA;
Dhanota, N;
Chatila, WK;
Bettigole, SE;
Kwon, J;
Sriram, RK;
... Bakhoum, SF; + view all
(2021)
Metastasis and Immune Evasion from Extracellular cGAMP Hydrolysis.
Cancer Discovery
, 11
(5)
pp. 1212-1227.
10.1158/2159-8290.CD-20-0387.
|
Lin, Lin;
Lin, Guangyao;
Zhou, Qingtong;
Bathgate, Ross AD;
Gong, Grace Qun;
Yang, Dehua;
Liu, Qing;
(2021)
Design, synthesis and pharmacological evaluation of tricyclic derivatives as selective RXFP4 agonists.
Bioorganic Chemistry
, 110
, Article 104782. 10.1016/j.bioorg.2021.104782.
|
Lindsay, CR;
Shaw, EC;
Moore, DA;
Rassl, D;
Jamal-Hanjani, M;
Steele, N;
Naheed, S;
... Kerr, KM; + view all
(2021)
Large cell neuroendocrine lung carcinoma: consensus statement from The British Thoracic Oncology Group and the Association of Pulmonary Pathologists.
British Journal of Cancer
10.1038/s41416-021-01407-9.
(In press).
|
Litchfield, K;
Reading, JL;
Puttick, C;
Thakkar, K;
Abbosh, C;
Bentham, R;
Watkins, TBK;
... Swanton, C; + view all
(2021)
Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition.
Cell
, 184
(3)
596-614.e14.
10.1016/j.cell.2021.01.002.
|
Llovet, JM;
Villanueva, A;
Marrero, JA;
Schwartz, M;
Meyer, T;
Galle, PR;
Lencioni, R;
... Roberts, LR; + view all
(2021)
Trial Design and Endpoints in Hepatocellular Carcinoma: AASLD Consensus Conference.
Hepatology
, 73
(S1)
pp. 158-191.
10.1002/hep.31327.
|
M
Madsen, RR;
Erickson, EC;
Rueda, OM;
Robin, X;
Caldas, C;
Toker, A;
Semple, RK;
(2021)
Positive correlation between transcriptomic stemness and PI3K/AKT/mTOR signaling scores in breast cancer, and a counterintuitive relationship with PIK3CA genotype.
PLOS Genetics
, 17
(11)
, Article e1009876. 10.1371/journal.pgen.1009876.
|
Madsen, RR;
Longden, J;
Knox, RG;
Robin, X;
Völlmy, F;
Macleod, KG;
Moniz, LS;
... Semple, RK; + view all
(2021)
NODAL/TGFβ signalling mediates the self-sustained stemness induced by PIK3CAH1047R homozygosity in pluripotent stem cells.
Disease Models & Mechanisms
10.1242/dmm.048298.
(In press).
|
Maiani, E;
Milletti, G;
Nazio, F;
Holdgaard, SG;
Bartkova, J;
Rizza, S;
Cianfanelli, V;
... Cecconi, F; + view all
(2021)
AMBRA1 regulates cyclin D to guard S-phase entry and genomic integrity.
Nature
, 592
(7856)
pp. 799-803.
10.1038/s41586-021-03422-5.
|
Main, KHS;
Provan, JI;
Haynes, PJ;
Wells, G;
Hartley, JA;
Pyne, ALB;
(2021)
Atomic force microscopy—A tool for structural and translational DNA research.
APL Bioengineering
, 5
(3)
, Article 031504. 10.1063/5.0054294.
(In press).
|
Mandair, D;
Khan, MS;
Lopes, A;
Furtado O'Mahony, L;
Ensell, L;
Lowe, H;
Hartley, JA;
... Meyer, T; + view all
(2021)
Prognostic Threshold for Circulating Tumor Cells in Patients With Pancreatic and Midgut Neuroendocrine Tumors.
Journal of Clinical Endocrinology and Metabolism
, 106
(3)
pp. 872-882.
10.1210/clinem/dgaa822.
|
Mansoor, W;
Arkenau, H-T;
Alsina, M;
Shitara, K;
Thuss-Patience, P;
Cuffe, S;
Dvorkin, M;
... Van Cutsem, E; + view all
(2021)
Trifluridine/tipiracil in patients with metastatic gastroesophageal junction cancer: a subgroup analysis from the phase 3 TAGS study.
Gastric Cancer
10.1007/s10120-021-01156-x.
(In press).
|
Marzec, J;
Ross-Adams, H;
Pirrò, S;
Wang, J;
Zhu, Y;
Mao, X;
Gadaleta, E;
... Chelala, C; + view all
(2021)
The Transcriptomic Landscape of Prostate Cancer Development and Progression: An Integrative Analysis.
Cancers
, 13
(2)
, Article 345. 10.3390/cancers13020345.
|
McAteer, MA;
O'Connor, JPB;
Koh, DM;
Leung, HY;
Doran, SJ;
Jauregui-Osoro, M;
Muirhead, N;
... Punwani, S; + view all
(2021)
Introduction to the National Cancer Imaging Translational Accelerator (NCITA): a UK-wide infrastructure for multicentre clinical translation of cancer imaging biomarkers.
British Journal of Cancer
10.1038/s41416-021-01497-5.
(In press).
|
Meng, B;
Kemp, SA;
Papa, G;
Datir, R;
Ferreira, IATM;
Marelli, S;
Harvey, WT;
... Gupta, RK; + view all
(2021)
Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7.
Cell Reports
, 35
(13)
, Article 109292. 10.1016/j.celrep.2021.109292.
|
Moore, DA;
Benafif, S;
Poskitt, B;
Argue, S;
Lee, SM;
Ahmad, T;
Papadatos-Pastos, D;
... Forster, MD; + view all
(2021)
Optimising fusion detection through sequential DNA and RNA molecular profiling of non-small cell lung cancer.
Lung Cancer
, 161
pp. 55-59.
10.1016/j.lungcan.2021.08.008.
|
Moreno, V;
Greil, R;
Yachnin, J;
Majem, M;
Wermke, M;
Arkenau, HT;
Basque, JR;
... Giovannini, M; + view all
(2021)
Pharmacokinetics and safety of capmatinib with food in patients with MET-dysregulated advanced solid tumors.
Clinical Therapeutics
10.1016/j.clinthera.2021.04.006.
|
Morka, N;
Simpson, BS;
Emberton, M;
Norris, JM;
(2021)
Re: Giorgio Gandaglia, Guillaume Ploussard, Massimo Valerio, et al. Prognostic Implications of Multiparametric Magnetic Resonance Imaging and Concomitant Systematic Biopsy in Predicting Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer Patients Diagnosed with Magnetic Resonance Imaging–targeted Biopsy. Eur Urol Oncol 2020;7:739–47.
European Urology Oncology
, 4
(1)
pp. 127-128.
10.1016/j.euo.2020.12.015.
|
Morka, N;
Simpson, BS;
Ball, R;
Freeman, A;
Kirkham, A;
Kelly, D;
Whitaker, HC;
... Norris, JM; + view all
(2021)
Clinical outcomes associated with prostate cancer conspicuity on biparametric and multiparametric MRI: a protocol for a systematic review and meta-analysis of biochemical recurrence following radical prostatectomy.
BMJ Open
, 11
(5)
, Article e047664. 10.1136/bmjopen-2020-047664.
|
Morotti, M;
Albukhari, A;
Alsaadi, A;
Artibani, M;
Brenton, JD;
Curbishley, SM;
Dong, T;
... Ahmed, AA; + view all
(2021)
Promises and challenges of adoptive T-cell therapies for solid tumours.
British Journal of Cancer
10.1038/s41416-021-01353-6.
(In press).
|
Mueller, V;
Wardley, A;
Paplomata, E;
Hamilton, E;
Zelnak, A;
Fehrenbacher, L;
Jakobsen, E;
... Gelmon, K; + view all
(2021)
Preservation of quality of life in patients with human epidermal growth factor receptor 2–positive metastatic breast cancer treated with tucatinib or placebo when added to trastuzumab and capecitabine (HER2CLIMB trial).
European Journal of Cancer
, 153
pp. 223-233.
10.1016/j.ejca.2021.05.025.
|
Muñoz-Martínez, S;
Sapena, V;
Forner, A;
Nault, J-C;
Sapisochin, G;
Rimassa, L;
Sangro, B;
... Reig, M; + view all
(2021)
Assessing the impact of COVID-19 on liver cancer management (CERO-19).
JHEP Reports
, Article 100260. 10.1016/j.jhepr.2021.100260.
(In press).
|
Mustapha, R;
Ng, K;
Monypenny, J;
Ng, T;
(2021)
Insights Into Unveiling a Potential Role of Tertiary Lymphoid Structures in Metastasis.
Frontiers in Molecular Biosciences
, 8
10.3389/fmolb.2021.661516.
|
N
Naing, A;
Thistlethwaite, F;
De Vries, EGE;
Eskens, FALM;
Uboha, N;
Ott, PA;
Lorusso, P;
... Spira, A; + view all
(2021)
CX-072 (pacmilimab), a Probody® PD-L1 inhibitor, in advanced or recurrent solid tumors (PROCLAIM-CX-072): an open-label dose-finding and first-in-human study.
Journal for ImmunoTherapy of Cancer
, 9
(7)
, Article e002447. 10.1136/jitc-2021-002447.
|
Nile, Donna L;
Rae, Colin;
Walker, David J;
Waddington, Joe Canning;
Vincent, Isabel;
Burgess, Karl;
Gaze, Mark N;
... Chalmers, Anthony J; + view all
(2021)
Inhibition of glycolysis and mitochondrial respiration promotes radiosensitisation of neuroblastoma and glioma cells.
Cancer and Metabolism
, 9
, Article 24. 10.1186/s40170-021-00258-5.
|
Norris, JM;
Carmona Echeverria, LM;
Simpson, BS;
Ball, R;
Freeman, A;
Kelly, D;
Kirkham, A;
... Emberton, M; + view all
(2021)
Conspicuity of cribriform prostate cancer on multiparametric magnetic resonance imaging: the jury is still out.
BJU International
, 127
(2)
pp. 169-170.
10.1111/bju.15295.
|
Norris, JM;
Simpson, BS;
Ball, R;
Freeman, A;
Kirkham, A;
Parry, MA;
Moore, CM;
... Emberton, M; + view all
(2021)
A Modified Newcastle-Ottawa Scale for Assessment of Study Quality in Genetic Urological Research.
European Urology
, 79
(3)
pp. 325-326.
10.1016/j.eururo.2020.12.017.
|
O
O'Connor, E;
Fourier, C;
Ran, C;
Sivakumar, P;
Liesecke, F;
Southgate, L;
Harder, AVE;
... Belin, AC; + view all
(2021)
Genome-Wide Association Study Identifies Risk Loci for Cluster Headache.
Annals of Neurology
, 90
(2)
pp. 193-202.
10.1002/ana.26150.
|
Olmedo, ME;
Forster, M;
Moreno, V;
Lopez-Criado, MP;
Brana, I;
Flynn, M;
Doger, B;
... Calvo, E; + view all
(2021)
Efficacy and safety of lurbinectedin and doxorubicin in relapsed small cell lung cancer. Results from an expansion cohort of a phase I study.
Investigational New Drugs
10.1007/s10637-020-01025-x.
(In press).
|
Opzoomer, JW;
Anstee, JE;
Dean, I;
Hill, EJ;
Bouybayoune, I;
Caron, J;
Muliaditan, T;
... Arnold, JN; + view all
(2021)
Macrophages orchestrate the expansion of a proangiogenic perivascular niche during cancer progression.
Science Advances
, 7
(45)
, Article eabg9518. 10.1126/sciadv.abg9518.
|
Opzoomer, JW;
Timms, JA;
Blighe, K;
Mourikis, TP;
Chapuis, N;
Bekoe, R;
Kareemaghay, S;
... Kordasti, S; + view all
(2021)
ImmunoCluster provides a computational framework for the non-specialist to profile high- dimensional cytometry data.
eLife
, 10
, Article e62915. 10.7554/eLife.62915.
(In press).
|
Orr, JC;
Hynds, RE;
(2021)
Stem Cell-Derived Respiratory Epithelial Cell Cultures as Human Disease Models.
American Journal of Respiratory Cell and Molecular Biology
10.1165/rcmb.2020-0440TR.
(In press).
|
P
Papoutsaki, M-V;
Sidhu, HS;
Dikaios, N;
Singh, S;
Atkinson, D;
Kanber, B;
Beale, T;
... Punwani, S; + view all
(2021)
Utility of diffusion MRI characteristics of cervical lymph nodes as disease classifier between patients with head and neck squamous cell carcinoma and healthy volunteers.
NMR in Biomedicine
, Article e4587. 10.1002/nbm.4587.
(In press).
|
Parker, Peter J;
Brown, Sophie J;
Calleja, Veronique;
Chakravarty, Probir;
Cobbaut, Mathias;
Linch, Mark;
Marshall, Jacqueline JT;
... Watson, Lisa; + view all
(2021)
Equivocal, explicit and emergent actions of PKC isoforms in cancer.
NATURE REVIEWS CANCER
, 21
(1)
pp. 51-63.
10.1038/s41568-020-00310-4.
|
Pearce, David;
(2021)
Investigation of fibulin-2 in pulmonary fibrosis.
Doctoral thesis (Ph.D), UCL (University College London).
|
Pemberton, L;
Ng, K;
McGovern, U;
Macdonald, A;
Barot, H;
Galazi, M;
Wilson, P;
... Shamash, J; + view all
(2021)
Febrile neutropenia (FN) rates in metastatic hormone sensitive prostate cancer: the role of antibiotics as primary prophylaxis.
Prostate Cancer and Prostatic Diseases
, 24
pp. 166-168.
10.1038/s41391-020-0261-z.
|
Peña, OA;
Lubin, A;
Hockings, C;
Rowell, J;
Jung, Y;
Hoade, Y;
Dace, P;
... Payne, EM; + view all
(2021)
TLR7 ligation augments hematopoiesis in Rps14 (uS11) deficiency via paradoxical suppression of inflammatory signaling.
Blood Advances
, 5
(20)
pp. 4112-4124.
10.1182/bloodadvances.2020003055.
|
Peneder, P;
Stutz, AM;
Surdez, D;
Krumbholz, M;
Semper, S;
Chicard, M;
Sheffield, NC;
... Tomazou, EM; + view all
(2021)
Multimodal analysis of cell-free DNA whole-genome sequencing for pediatric cancers with low mutational burden.
Nature Communications
, 12
(1)
, Article 3230. 10.1038/s41467-021-23445-w.
|
Pinato, DJ;
Scotti, L;
Gennari, A;
Colomba-Blameble, E;
Dolly, S;
Loizidou, A;
Chester, J;
... Cortellini, A; + view all
(2021)
Determinants of enhanced vulnerability to COVID-19 in UK cancer patients: a European Study.
European Journal of Cancer
, 150
pp. 190-202.
10.1016/j.ejca.2021.03.035.
|
Pinato, DJ;
Tabernero, J;
Bower, M;
Scotti, L;
Patel, M;
Colomba, E;
Dolly, S;
... Iglesias, M; + view all
(2021)
Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study.
The Lancet Oncology
10.1016/s1470-2045(21)00573-8.
(In press).
|
Pirrò, S;
Matic, I;
Colizzi, V;
Galgani, A;
(2021)
The microRNA analysis portal is a next-generation tool for exploring and analyzing miRNA-focused data in the literature.
Scientific Reports
, 11
, Article 9007. 10.1038/s41598-021-88617-6.
|
Pocock, R;
Farah, N;
Richardson, SE;
Mansour, MR;
(2021)
Current and emerging therapeutic approaches for T-cell acute lymphoblastic leukaemia.
British Journal of Haematology
10.1111/bjh.17310.
(In press).
|
Prele, CM;
Iosifidis, T;
McAnulty, RJ;
Pearce, DR;
Badrian, B;
Miles, T;
Jamieson, SE;
... Mutsaers, SE; + view all
(2021)
Reduced SOCS1 Expression in Lung Fibroblasts from Patients with IPF Is Not Mediated by Promoter Methylation or Mir155.
Biomedicines
, 9
(5)
, Article 498. 10.3390/biomedicines9050498.
|
Puglisi, M;
Molife, LR;
de Jonge, MJ;
Khan, KH;
Doorn, LV;
Forster, MD;
Blanco, M;
... Eskens, FA; + view all
(2021)
A Phase I study of the safety, pharmacokinetics and efficacy of navitoclax plus docetaxel in patients with advanced solid tumors.
Future Oncology
10.2217/fon-2021-0140.
(In press).
|
Punjabi, A;
Barrett, E;
Cheng, A;
Mulla, A;
Walls, G;
Johnston, D;
McAleese, J;
... Evison, M; + view all
(2021)
Neutrophil-Lymphocyte Ratio and Absolute Lymphocyte Count as Prognostic Markers in Patients Treated with Curative-intent Radiotherapy for Non-small Cell Lung Cancer.
Clinical Oncology
, 33
(8)
e331-e338.
10.1016/j.clon.2021.03.019.
|
Pye, H;
Singh, S;
Norris, JM;
Carmona Echeverria, LM;
Stavrinides, V;
Grey, A;
Dinneen, E;
... Whitaker, HC; + view all
(2021)
Evaluation of PSA and PSA Density in a Multiparametric Magnetic Resonance Imaging-Directed Diagnostic Pathway for Suspected Prostate Cancer: The INNOVATE Trial.
Cancers
, 13
(8)
, Article 1985. 10.3390/cancers13081985.
|
R
Rabanal-Ruiz, Y;
Byron, A;
Wirth, A;
Madsen, R;
Sedlackova, L;
Hewitt, G;
Nelson, G;
... Korolchuk, VI; + view all
(2021)
mTORC1 activity is supported by spatial association with focal adhesions.
Journal of Cell Biology
, 220
(5)
, Article e202004010. 10.1083/jcb.202004010.
|
Rane, Jayant K;
Chowdhury, Amani;
Kinnaird, William;
Marks, Gillian;
Davda, Reena;
(2021)
Treatment of metastatic hormone‐sensitive prostate cancer.
Trends in Urology & Men's Health
, 12
(6)
pp. 7-10.
10.1002/tre.824.
|
Rauf, A;
Razzaq, S;
Tabish, TA;
Tahseen, S;
Sandhu, MA;
Shahnaz, G;
(2021)
Investigating the intracellular bactericidal effects of rifampicin loaded S-protected thiomeric chitosan nanocargoes against Mycobacterium tuberculosis.
Journal of Drug Delivery Science and Technology
, 61
, Article 102184. 10.1016/j.jddst.2020.102184.
|
Richardson, SE;
Ghazanfari, R;
Chhetri, J;
Enver, T;
Böiers, C;
(2021)
In vitro differentiation of human pluripotent stem cells into the B lineage using OP9-MS5 co-culture.
STAR Protocols
, 2
(2)
, Article 100420. 10.1016/j.xpro.2021.100420.
|
Rimassa, Lorenza;
Kelley, Robin Kate;
Meyer, Tim;
Ryoo, Baek-Yeol;
Merle, Philippe;
Park, Joong-Won;
Blanc, Jean-Frederic;
... Abou-Alfa, Ghassan K; + view all
(2021)
Outcomes Based on Plasma Biomarkers for the Phase 3 CELESTIAL Trial of Cabozantinib versus Placebo in Advanced Hepatocellular Carcinoma.
Liver Cancer
, 11
(1)
pp. 38-47.
10.1159/000519867.
|
Roddie, C;
Dias, J;
O'Reilly, MA;
Abbasian, M;
Cadinanos-Garai, A;
Vispute, K;
Bosshard-Carter, L;
... Peggs, KS; + view all
(2021)
Durable Responses and Low Toxicity After Fast Off-Rate CD19 Chimeric Antigen Receptor-T Therapy in Adults With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia.
Journal of Clinical Oncology
10.1200/jco.21.00917.
(In press).
|
Rosenthal, R;
Swanton, C;
McGranahan, N;
(2021)
Understanding the impact of immune-mediated selection on lung cancer evolution.
British Journal of Cancer
, 124
(10)
pp. 1615-1617.
10.1038/s41416-020-01232-6.
|
Round, T;
L'Esperance, V;
Bayly, J;
Brain, K;
Dallas, L;
Edwards, JG;
Haswell, T;
... Navani, N; + view all
(2021)
COVID-19 and the multidisciplinary care of patients with lung cancer: an evidence-based review and commentary.
British Journal of Cancer
, 125
pp. 629-640.
10.1038/s41416-021-01361-6.
|
Rush, HL;
Murphy, L;
Morgans, AK;
Clarke, NW;
Cook, AD;
Attard, G;
Macnair, A;
... Langley, RE; + view all
(2021)
Quality of Life in Men With Prostate Cancer Randomly Allocated to Receive Docetaxel or Abiraterone in the STAMPEDE Trial.
Journal of Clinical Oncology
10.1200/JCO.21.00728.
(In press).
|
S
Saifuddin, A;
Baig, MS;
Dalal, P;
Strauss, SJ;
(2021)
The diagnosis of pulmonary metastases on chest computed tomography in primary bone sarcoma and musculoskeletal soft tissue sarcoma.
British Journal of Radiology
, 94
(1123)
, Article 20210088. 10.1259/bjr.20210088.
|
Sashittal, P;
Zaccaria, S;
El-Kebir, M;
(2021)
Parsimonious clone tree reconciliation in cancer.
In:
21st International Workshop on Algorithms in Bioinformatics (WABI 2021).
(pp. 9:1-9:21).
Schloss Dagstuhl -- Leibniz-Zentrum für Informatik: Dagstuhl, Germany.
|
Satas, G;
Zaccaria, S;
El-Kebir, M;
Raphael, BJ;
(2021)
DeCiFering the elusive cancer cell fraction in tumor heterogeneity and evolution.
Cell Systems
, 12
(10)
1004-1018.e10.
10.1016/j.cels.2021.07.006.
|
Satish, P;
Simpson, B;
Freeman, A;
Giganti, F;
Kirkham, A;
Orczyk, C;
Whitaker, H;
... Norris, JM; + view all
(2021)
Mapping Contemporary Biopsy Zones to Traditional Prostatic Anatomy: The Key to Understanding Relationships Between Prostate Cancer Topography, Magnetic Resonance Imaging Conspicuity, and Clinical Risk.
European Urology
, 80
(2)
pp. 263-265.
10.1016/j.eururo.2021.05.017.
|
Schmidt, NM;
Wing, PAC;
Diniz, MO;
Pallett, LJ;
Swadling, L;
Harris, JM;
Burton, AR;
... Maini, MK; + view all
(2021)
Targeting human Acyl-CoA:cholesterol acyltransferase as a dual viral and T cell metabolic checkpoint.
Nature Communications
, 12
, Article 2814. 10.1038/s41467-021-22967-7.
|
Schöffski, P;
Kubickova, M;
Wozniak, A;
Blay, JY;
Strauss, SJ;
Stacchiotti, S;
Switaj, T;
... Kasper, B; + view all
(2021)
Long-term efficacy update of crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumour from EORTC trial 90101 CREATE.
European Journal of Cancer
, 156
pp. 12-23.
10.1016/j.ejca.2021.07.016.
|
Sereno, M;
He, Z;
Smith, CR;
Baena, J;
Das, M;
Hastings, RK;
Rake, G;
... Le Quesne, J; + view all
(2021)
Inclusion of multiple high‐risk histopathological criteria improves the prediction of adjuvant chemotherapy efficacy in lung adenocarcinoma.
Histopathology
10.1111/his.14301.
(In press).
|
Shamji, MH;
Singh, I;
Layhadi, JA;
Ito, C;
Karamani, A;
Kouser, L;
Sharif, H;
... Radin, AR; + view all
(2021)
Passive Prophylactic Administration with a Single Dose of Anti-Fel d 1 Monoclonal Antibodies REGN1908-1909 in Cat Allergen-Induced Allergic Rhinitis: A Randomized, Double-blind, Placebo Controlled Trial.
American Journal of Respiratory and Critical Care Medicine
, 204
(1)
pp. 23-33.
10.1164/rccm.202011-4107OC.
|
Shen, J;
Zhuang, W;
Xu, C;
Jin, K;
Chen, B;
Tian, D;
Hiley, C;
... Qiao, G; + view all
(2021)
Surgery or Non-surgical Treatment of <= 8 mm Non-small Cell Lung Cancer: A Population-Based Study.
Frontiers in Surgery
, 8
, Article ARTN 632. 10.3389/fsurg.2021.632561.
|
Simpson, BS;
Pye, H;
Whitaker, HC;
(2021)
The oncological relevance of fragile sites in cancer.
Communications Biology
, 4
(1)
, Article 567. 10.1038/s42003-021-02020-5.
|
Soosaipillai, G;
Wu, A;
Dettorre, GM;
Diamantis, N;
Chester, J;
Moss, C;
Aguilar-Company, J;
... Izuzquiza, M; + view all
(2021)
Specialist palliative and end-of-life care for patients with cancer and SARS-CoV-2 infection: a European perspective.
Therapeutic Advances in Medical Oncology
, 13
pp. 1-17.
10.1177/17588359211042224.
|
Stacchiotti, S;
Miah, AB;
Frezza, AM;
Messiou, C;
Morosi, C;
Caraceni, A;
Antonescu, CR;
... Gronchi, A; + view all
(2021)
Enithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of experts.
ESMO OPEN
, 6
(3)
, Article 100170. 10.1016/j.esmoop.2021.100170.
|
Strauss, SJ;
Frezza, AM;
Abecassis, N;
Bajpai, J;
Bauer, S;
Biagini, R;
Bielack, S;
... Stacchiotti, S; + view all
(2021)
Bone sarcomas: ESMO-EURACAN-GENTURIS-ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up.
Annals of Oncology
, 32
(12)
pp. 1520-1536.
10.1016/j.annonc.2021.08.1995.
|
Sufi, J;
Qin, X;
Rodriguez, FC;
Bu, YJ;
Vlckova, P;
Zapatero, MR;
Nitz, M;
(2021)
Multiplexed single-cell analysis of organoid signaling networks.
Nature Protocols
, 16
pp. 4897-4918.
10.1038/s41596-021-00603-4.
|
Sun, H;
Cao, S;
Mashl, RJ;
Mo, C-K;
Zaccaria, S;
Wendl, MC;
Davies, SR;
... Ding, L; + view all
(2021)
Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidatesfor targeted treatment.
Nature Communications
, 12
, Article 5086. 10.1038/s41467-021-25177-3.
|
Szikriszt, B;
Póti, Á;
Németh, E;
Kanu, N;
Swanton, C;
Szüts, D;
(2021)
A comparative analysis of the mutagenicity of platinum-containing chemotherapeutic agents reveals direct and indirect mutagenic mechanisms.
Mutagenesis
, 36
(1)
pp. 75-86.
10.1093/mutage/geab005.
|
T
Taavitsainen, S;
Engedal, N;
Cao, S;
Handle, F;
Erickson, A;
Prekovic, S;
Wetterskog, D;
... Urbanucci, A; + view all
(2021)
Single-cell ATAC and RNA sequencing reveal pre-existing and persistent cells associated with prostate cancer relapse.
Nature Communications
, 12
(1)
, Article 5307. 10.1038/s41467-021-25624-1.
|
Tabernero, J;
Grothey, A;
Van Cutsem, E;
Yaeger, R;
Wasan, H;
Yoshino, T;
Desai, J;
... Kopetz, S; + view all
(2021)
Encorafenib Plus Cetuximab as a New Standard of Care for Previously Treated BRAF V600E–Mutant Metastatic Colorectal Cancer: Updated Survival Results and Subgroup Analyses from the BEACON Study.
Journal of Clinical Oncology
, 39
(4)
pp. 273-284.
10.1200/JCO.20.02088.
|
Tabish, TA;
Abbas, A;
Narayan, RJ;
(2021)
Graphene nanocomposites for transdermal biosensing.
Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology
, 13
(4)
, Article e1699. 10.1002/wnan.1699.
|
Terziev, R;
Psimaras, D;
Marie, Y;
Feuvret, L;
Berzero, G;
Jacob, J;
Dehais, C;
... Ricard, D; + view all
(2021)
Cumulative incidence and risk factors for radiation induced leukoencephalopathy in high grade glioma long term survivors.
Scientific Reports
, 11
(1)
, Article 10176. 10.1038/s41598-021-89216-1.
|
Thol, K;
McGranahan, N;
(2021)
Potential Use of Shared Frameshift Mutations in 'Off-the-Shelf' Neoantigen Vaccines.
Trends in Cancer
, 7
(3)
pp. 175-177.
10.1016/j.trecan.2021.01.002.
|
V
van Maldegem, F;
Valand, K;
Cole, M;
Patel, H;
Angelova, M;
Rana, S;
Colliver, E;
... Downward, J; + view all
(2021)
Characterisation of tumour microenvironment remodelling following oncogene inhibition in preclinical studies with imaging mass cytometry.
Nature Communications
, 12
(1)
, Article 5906. 10.1038/s41467-021-26214-x.
|
Vanhaesebroeck, B;
Perry, MWD;
Brown, JR;
André, F;
Okkenhaug, K;
(2021)
PI3K inhibitors are finally coming of age.
Nature Reviews Drug Discovery
, 20
pp. 741-769.
10.1038/s41573-021-00209-1.
|
Vendramin, R;
Litchfield, K;
Swanton, C;
(2021)
Cancer evolution: Darwin and beyond.
EMBO Journal
, Article e108389. 10.15252/embj.2021108389.
|
Venkatesan, S;
Angelova, M;
Bartkova, J;
Bakhoum, SF;
Bartek, J;
Kanu, N;
Swanton, C;
(2021)
APOBEC3 as a driver of genetic intratumor heterogeneity.
Molecular and Cellular Oncology
10.1080/23723556.2021.2014734.
(In press).
|
Venkatesan, S;
Angelova, M;
Puttick, C;
Zhai, H;
Caswell, DR;
Lu, W-T;
Dietzen, M;
... Consortium, T; + view all
(2021)
Induction of APOBEC3 Exacerbates DNA Replication Stress and Chromosomal Instability in Early Breast and Lung Cancer Evolution.
Cancer Discovery
, 11
(10)
pp. 2456-2473.
10.1158/2159-8290.CD-20-0725.
|
Volz, E;
Mishra, S;
Chand, M;
Barrett, JC;
Johnson, R;
Geidelberg, L;
Hinsley, WR;
... Ferguson, NM; + view all
(2021)
Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England.
Nature
, 593
(7858)
pp. 266-269.
10.1038/s41586-021-03470-x.
|
Vusirikala, A;
Ensor, D;
Asokan, AK;
Lee, AJX;
Ray, R;
Tsekes, D;
Edwin, J;
(2021)
Hello, can you hear me? Orthopaedic clinic telephone consultations in the COVID-19 era- a patient and clinician perspective.
World Journal of Orthopedics
, 12
(1)
pp. 24-34.
10.5312/wjo.v12.i1.24.
|
W
Wainberg, ZA;
Fuchs, CS;
Tabernero, J;
Shitara, K;
Muro, K;
Van Cutsem, E;
Bang, Y-J;
... Chao, J; + view all
(2021)
Efficacy of Pembrolizumab Monotherapy for Advanced Gastric/Gastroesophageal Junction Cancer with Programmed Death Ligand 1 Combined Positive Score ≥10.
Clinical Cancer Research
, 27
(7)
pp. 1923-1931.
10.1158/1078-0432.CCR-20-2980.
|
Wall, EC;
Wu, M;
Harvey, R;
Kelly, G;
Warchal, S;
Sawyer, C;
Daniels, R;
... Bauer, DL; + view all
(2021)
AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC.
The Lancet
10.1016/S0140-6736(21)01462-8.
(In press).
|
Wall, EC;
Wu, M;
Harvey, R;
Kelly, G;
Warchal, S;
Sawyer, C;
Daniels, R;
... Bauer, DLV; + view all
(2021)
Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination.
The Lancet
10.1016/s0140-6736(21)01290-3.
(In press).
|
Wong, YNS;
Sng, CCT;
Ottaviani, D;
Patel, G;
Chowdhury, A;
Earnshaw, I;
Sinclair, A;
... Lee, AJX; + view all
(2021)
Systemic anti-cancer therapy and metastatic cancer are independent mortality risk factors during two uk waves of the covid-19 pandemic at university college london hospital.
Cancers
, 13
(23)
, Article 6085. 10.3390/cancers13236085.
|
Wu, Y;
Biswas, D;
Swanton, C;
(2021)
Impact of cancer evolution on immune surveillance and checkpoint inhibitor response.
Seminars in Cancer Biology
10.1016/j.semcancer.2021.02.013.
(In press).
|
Z
Zhang, Hanyun;
Grunewald, Tami;
Akarca, Ayse U;
Ledermann, Jonathan A;
Marafioti, Teresa;
Yuan, Yinyin;
(2021)
Symmetric Dense Inception Network for Simultaneous Cell
Detection and Classification in Multiplex Immunohistochemistry Images.
In: Atzori, Manfredo and Burlutskiy, Nikolay and Ciompi, Francesco and Li, Zhang and Minhas, Fayyaz and Müller, Henning and Peng, Tingying and Rajpoot, Nasir and Torben_Nielsen, Ben and van der Laak, Jeroen and Veta, Mitko and Yuan, Yinyin and Zlobec, Inti, (eds.)
Proceedings of the MICCAI Workshop on Computational Pathology.
(pp. pp. 246-257).
PMLR
|
Zhang, M;
Luo, J-L;
Sun, Q;
Harber, J;
Dawson, AG;
Nakas, A;
Busacca, S;
... Fennell, DA; + view all
(2021)
Clonal architecture in mesothelioma is prognostic and shapes the tumour microenvironment.
Nature Communications
, 12
(1)
, Article 1751. 10.1038/s41467-021-21798-w.
|
Zhao, Y;
Fu, X;
Lopez, JI;
Rowan, A;
Au, L;
Fendler, A;
Hazell, S;
... Litchfield, K; + view all
(2021)
Selection of metastasis competent subclones in the tumour interior.
Nature Ecology & Evolution
, 5
pp. 1033-1045.
10.1038/s41559-021-01456-6.
|
Zhao, Y;
Morka, N;
Simpson, BSS;
Freeman, A;
Kirkham, A;
Kelly, D;
Whitaker, HC;
... Norris, JM; + view all
(2021)
Prostate-specific membrane antigen positron emission tomography compared to multiparametric MRI for prostate cancer diagnosis: a protocol for a systematic review and meta-analysis.
BMJ Open
, 11
(12)
, Article e052277. 10.1136/bmjopen-2021-052277.
|
Zoumpoulidou, G;
Alvarez-Mendoza, C;
Mancusi, C;
Ahmed, R-M;
Denman, M;
Steele, CD;
Tarabichi, M;
... Mittnacht, S; + view all
(2021)
Therapeutic vulnerability to PARP1,2 inhibition in RB1-mutant osteosarcoma.
Nature Communications
, 12
(1)
, Article 7064. 10.1038/s41467-021-27291-8.
|